Besides, recent colorectal cancer tumor markers, such as CEA and CA19‐9, have been confirmed to have obvious limitations in their diagnostic sensitivity and specificity, especially in patients with early colorectal cancer, whose diagnostic efficacy is weak. Here, CEACAM5 is linked to neoplasm.